Ang Lifesciences India Ltd Share Price Today, Live NSE/BSE Updates

NSEBSE

There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.

Max

Open-

High-

Low-

Prev. Close-

Avg. Traded Price-

Volume-

MARKET DEPTH

Total bid0.00

Total ask0.00

Orders	Qty	Bid

Ask	Qty	Orders

HIGH/LOW

52w

LOW/HIGH

LOWER/UPPER CIRCUITS

Ang Lifesciences India Ltd Stock performance

KEY OBSERVATIONS

positive

negative

neutral

Quarterly Net profit,rose 43.5% YoY to ₹2.06 Cr. Its sector's average net profit growth YoY for the quarter was 21.52%.

LONG-TERM PRICE ANALYSIS

Stock return5Y CAGR : 18.61%

Net profit growth 5Y CAGR : %

Similar stocks

SUNPHARMA₹1,629.70-77.00 (4.51%)

DIVISLAB₹6,361.50-234.00 (3.55%)

TORNTPHARM₹3,678.20-63.70 (1.70%)

CIPLA₹1,502.80-51.80 (3.33%)

MANKIND₹2,566.30-0.90 (0.04%)

ANG Lifesciences India is ISO-9001:2008 certified and has the modern & sophisticated plant equipments technique and manpower. The planning and construction of plant has been done to conform to the regulatory requirements as per the norms of WHO G.M.P. and G.L.P. as per schedule-M (revised). They manufacture their products in compliance with GMP requirements. They have dedicated area machinery facilities and advanced equipments for manufacturing of B-Lactum & Non-B Lactum products as per GMP Norms. The production block provides appropriate personnel and material flow. As per GMP norms all the production processes are documented and validated to establish the accuracy of the procedures and the control measures. The Company’s production capacity is 700 Lakhs Pcs per annum on per shift basis. Their products include sterile dry powder vials for Anti Biotics Anti Ulcerant Gluco corticoid and Anti inflammatory Anti malarial and Anesthetic.

Grow your wealth with more research recommendations

+91

To visit the old Ventura website, click here.

Ventura Wealth Clients Login here